q2

Lululemon Shares Jump on Better-than-Expected Earnings

Lululemon Shares Jump on Better-than-Expected Earnings

Shares of Lululemon Athletica Inc. (NASDAQ: LULU) soared on Friday after the athletic retailer reported second quarter earnings that beat analysts’ estimates, boosted by strong growth in online sales.The Company said net revenue rose 25% to US..

Boeing Company Shares Dropped After Second-Quarter Results

Boeing Company Shares Dropped After Second-Quarter Results

The Boeing Company (NYSE: BA) reported its second-quarter earnings and revenue on Wednesday. Shares of Boeing dropped 3.2% in premarket trade today.According to the company, revenue for the second quarter increased to $24.3 billion, which beat analy..

Morgan Stanley Shares Surged After Better-than-Expected Results

Morgan Stanley Shares Surged After Better-than-Expected Results

On Wednesday, Morgan Stanley (NYSE: MS) reported its financial results for the second quarter of fiscal 2018. With both earnings and revenue surpassing estimates, shares of the company surged 3.3% in premarket trading today.According to the company,..

Wall Street Remains Divided on Netflix’s Second Quarter

Wall Street Remains Divided on Netflix’s Second Quarter

Netflix Inc. (NASDAQ: NFLX) shares have surged 110% this year alone, becoming the best performer in the S&P 500. Despite its rally, Deutsche Bank warns that the tech giant may miss its second quarter subscriber estimates, but Wall Street remains..

Pepsico's Second-Quarter Earnings Beat Expectation

Pepsico's Second-Quarter Earnings Beat Expectation

On Tuesday, PepsiCo, Inc. (NASDAQ: PEP) announced its financial results for the second quarter of fiscal 2018. Both earnings and revenue beat analysts’ estimates, and shares of the company rallied 1.7% in premarket trading on Tuesday.According..

AstraZeneca Shares fell on Disappointing Q2 Results and Cancer Study Results

AstraZeneca Shares fell on Disappointing Q2 Results and Cancer Study Results

AstraZeneca plc (NYSE: AZN) released a bevy of news today, including Q2 results, as well as study results for two drugs. AZN price has plummeted 15%.Following the loss of exclusivity for Crestor and Seroquel XR AstraZeneca had expected losses in the..